C12N 2506/03
From non-embryonic pluripotent stem cells
Official title: from non-embryonic pluripotent stem cells
C12N2506/03 (From non-embryonic pluripotent stem cells) appears on 253 US grants and 475 published applications in this corpus.
Search patents in C12N- Granted patents
- 253
- Published applications
- 475
- Assignees
- 199
- Inventors
- 727
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 0 | 3 |
| 2004 | 1 | 4 |
| 2005 | 1 | 17 |
| 2006 | 1 | 16 |
| 2007 | 0 | 17 |
| 2008 | 1 | 6 |
| 2009 | 9 | 14 |
| 2010 | 4 | 8 |
| 2011 | 3 | 11 |
| 2012 | 7 | 5 |
| 2013 | 11 | 13 |
| 2014 | 9 | 14 |
| 2015 | 10 | 22 |
| 2016 | 15 | 21 |
| 2017 | 11 | 27 |
| 2018 | 16 | 32 |
| 2019 | 20 | 38 |
| 2020 | 21 | 36 |
| 2021 | 29 | 24 |
| 2022 | 12 | 36 |
| 2023 | 15 | 41 |
| 2024 | 22 | 22 |
| 2025 | 22 | 30 |
| 2026 | 13 | 16 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods related to megakaryocyte-derived extracellular vesicles4 Aug 2026US 12,697,307 B2STRM.bio Incorporated
- NK cell compositions and preparations for immunotherapy and methods for their production16 Jun 2026US 12,655,190 B2Deverra Therapeutics Inc.
- Genomic engineering of pluripotent cells2 Jun 2026US 12,642,852 B1Fate Therapeutics, Inc.
- Innervated organoid compositions and methods of making same14 Apr 2026US 12,600,943 B2Children's Hospital Medical Center
- Universal donor cells24 Mar 2026US 12,584,144 B2Crispr Therapeutics AG
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Methods and Culture Substrates for Controlled Induction of Biomimetic Neural Tissues Comprising Singular Rosette Structures30 Jul 2026US 2026/0218125 A1Wisconsin Alumni Research Foundation
- Engineered natural killer cells and related methods23 Jul 2026US 2026/0209705 A1Astellas Pharma Inc.
- Method for differentiating neural crest stem cells comprising axial specification information16 Jul 2026US 2026/0201324 A1Bless Biotherapeutics Inc.
- Method for inducing dopaminergic neuron progenitor cells16 Jul 2026US 2026/0201325 A1Eisai R&D Management Co., Ltd.
Most cited
By later US patents
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same84US 7,510,873 B2Ethicon, Inc. · 2009
- Soft tissue repair and regeneration using postpartum-derived cells76US 7,560,276 B2Ethicon, Inc. · 2009
- Treatment of Parkinson's disease and related disorders using postpartum derived cells67US 7,875,273 B2Ethicon, Inc. · 2011
- Regeneration and repair of neural tissue using postpartum-derived cells58US 7,524,489 B2Ethicon, Inc. · 2009